Cancer BiomarkersFDA NewsLeukemiaNewsworthy
This is the first time the FDA has used minimal residual disease (MRD) as a biomarker to approve a specific treatment for patients with acute lymphoblastic leukemia (ALL).
Breast CancerCancer BiomarkersCancer Screening
What Are Biomarkers in Breast Cancer, and How Do They Affect My Treatment? Interview with Daniel F. Hayes, MD, FACP, FASCO
Dr Hayes, Immediate Past President of ASCO and Professor of Breast Cancer Research at the University of Michigan Comprehensive Cancer Center, explains how biomarkers offer more precise treatment opportunities for patients with breast cancer.
By Dana Taylor
Read about important advancements in tumor biomarkers and their role in guiding treatment in some types of cancer.
In recent years, new treatments for acute myeloid leukemia have improved outcomes. In 2017, 2 new drugs were approved for patients with this type of blood cancer linked to a specific biomarker.
Cancer BiomarkersCancer Screening
Biomarkers are biologic markers that indicate changes in our genes and may increase the risk of cancer.
Patient AdvocacyPatient StoriesCancer Biomarkers
Wenora Y. Johnson, 3-time survivor, shares her cancer story and encourages patients to ask their care team about biomarker testing.
Web ExclusivesCancer Biomarkers
By Tracy Wright
A new study that included 500 women with uterine cancer diagnosed between 1981 and 2007 led to the discovery of a biomarker that may be able to identify those who are at high risk for uterine cancer recurrence.
Results 1 - 8 of 8